San Francisco CEO 2026

San Francisco CEO brought together over 300 leading biopharma CEOs, heads of R&D, top academic researchers, and life science investors to kick off JP Morgan week in San Francisco.

Featured Speakers

World-class innovators, researchers, and operators shared their insights in off-the-record discussion panels and fireside chats on a wide range of topics impacting the healthcare environment. Key stakeholders hailed from cross-industry sectors, including the following speakers:

Renowned Academics & Researchers

Carolyn Bertozzi

Nobel laureate; Professor
Stanford University

World-class CEOs

Hal Barron

CEO
Altos Labs

Pharma R&D Leaders

Sharon Barr

EVP, Head, BioPharmaceuticals R&D
AstraZeneca

Top Strategy Executives

Ronny Gal

Chief Strategy Officer
Novartis

Leading Biotech CEOs

Marianne De Backer

CEO
Vir Bio

Research & Regulatory Leaders

Julian Adams

CEO
Stand Up To Cancer

Blue-chip Investors

Lovisa Afzelius

General Partner
Flagship Pioneering

San Francisco CEO 2026 Highlights

Meeting participants enjoyed convening with a senior peer group in between dynamic and timely discussions across a wide spectrum of top issues facing the life science ecosystem today.